Cover Image
市場調查報告書

心室輔助裝置市場分析:各產品 (左心室,右心室,兩心室輔助裝置) 及至2022年的市場區隔預測

Ventricular Assist Device Market Analysis by Product (Left, Right, Bi- Ventricular Assist Devices), and Segment Forecasts To 2022

出版商 Grand View Research, Inc. 商品編碼 355226
出版日期 內容資訊 英文 81 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
心室輔助裝置市場分析:各產品 (左心室,右心室,兩心室輔助裝置) 及至2022年的市場區隔預測 Ventricular Assist Device Market Analysis by Product (Left, Right, Bi- Ventricular Assist Devices), and Segment Forecasts To 2022
出版日期: 2015年11月03日 內容資訊: 英文 81 Pages
簡介

全球心室輔助裝置市場,預計至2022年達到19億7,000萬美元。隨著心血管疾病的罹患率上升,配備預防感染技術的小型設備等的技術性進化的產品開發進行,成為讓市場急速成長的要素。還有優選的醫療費擴大的償付政策,最新技術設施的增加也支撐今後7年的市場成長。

本報告提供全球心室輔助裝置市場現狀與至2022年的成長預測,各產品趨勢,以及主要企業的簡介等彙整。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場趨勢
  • 促進要素
  • 阻礙要素
  • 市場機會
  • 產業分析:波特
  • 技術趨勢分析
  • 企業市場佔有率分析
  • PESTEL分析

第4章 各產品市場預測

  • 各產品收益佔有率
  • 左心室輔助裝置
  • 右心室輔助裝置
  • 兩心室輔助裝置

第5章 各地區預測

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第6章 競爭環境

  • Abiomed
  • HeartWare International
  • Thoratec
  • Berlin Heart
  • Cardiac Assist
  • Jarvik Heart
  • Reliantheart
  • Sun Medical Technology Research

圖表

目錄
Product Code: 978-1-68038-603-5

The global ventricular assist device market is expected to reach USD 1.97 billion by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to its rapid growth include rising prevalence of cardiovascular disorders coupled with the development of technological advanced products such as miniature device with infection reduction technology.

Furthermore, increasing healthcare expenditure, favorable reimbursement policies and advanced technological facilities, are expected to positively reinforce ventricular assist device market growth over the next seven years.

Ventricular assist device market is segmented on the basis of type of product which includes left ventricular, right ventricular and bi-ventricular assist device. Key factors attributing to rapidly increasing number of patients with end stage heart failure and low availability of therapeutic options are among the key factors attributing to the market growth.

With continual shortage of organ donors and increasing demand of LVADs' for bridge to transplantation in patients suffering from end stage heart failure, is expected to positively reinforce market growth over the forecast period.

Lack of developed reimbursement policies in underdeveloped economies of Africa and Asia is one of the key factors attributing for low penetration of these device. However, constant economic development, improving healthcare infrastructure and reimbursement policies in countries such as India and China is expected to positively reinforce market growth in next seven years.

Technological advancements in VADs have been a continuous process since the launch of first generation device. First generation VADs are referred to as pulsatile volume displacement pumps which are powered by pneumatic or electrical drive systems. Some of the U.S. FDA approved products are the Abiomed BVS5000, Worldheart Novacor System (LVAS).

Second generation ventricular assist device which are usually known as continuous flow LVADs were developed to overcome several limitations of the pulsatile displacement systems. At present, second generation LVADs that are available include the TandemHeart pVAD, Thoratec Heartmate II, Jarvik 2000, and the Impella Pump System.

Third generation ventricular assist device such as VentrAssist, DuraHeart, HeartMate III LVAD and others are currently under various stages of development, clinical trials and commercialization stages. These third generation ventricular assist device are continuous flow device with more advancement in product design, materials, battery capacity and size. Constant development in these devices serves as a high impact rendering driver for the growth of the market.

Further key findings from the report suggest:

In 2014, North America accounted for largest market share of over55%. Key factors attributing to its large share include presence of advanced healthcare infrastructure, and high level of collaboration between various stakeholders including medical fraternity, medical device industry, regulatory authorities, universities and others.

Furthermore, presence of high research expenditure by public and private entities in healthcare sector is anticipated to propel market growth for ventricular assist device in the coming seven years.

Asia Pacific is expected to be one of the fastest growing markets, growing at a CAGR of over17% during the forecast period. Key factors attributed to the growth are high economic growth in countries such as China, Brazil, India, and South Korea coupled with high unmet medical needs is expected to boost usage rates of ventricular assist device.

Key players operating in ventricular assist device market include Abiomed, HeartWare International, Thoratec, Inc., Berlin Heart, Cardiac Assist and ReliantHeart

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Scope & Assumptions
  • 1.3. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Ventricular Assist device- Industry Snapshot and Key Buying Criteria, 2012 - 2022

Chapter 3. Ventricular assist device Industry Outlook

  • 3.1. Ventricular assist device market segmentation
  • 3.2. Ventricular assist device market size and growth prospects
  • 3.3. Ventricular assist device Market dynamics
  • 3.4. Market driver analysis
  • 3.5. Market restraint analysis
  • 3.6. Key opportunities prioritized
  • 3.7. Industry analysis - Porter's
  • 3.8. Ventricular assist device technology trend analysis
  • 3.9. Company market share analysis, 2014
  • 3.10. Ventricular assist device: PESTEL analysis, 2014

Chapter 4. Ventricular Assist device Product Outlook

  • 4.1. Ventricular assist device market share, by product, 2014 & 2022
  • 4.2. Left ventricular assist device
    • 4.2.1. Left ventricular assist device market estimates and forecasts, 2012 - 2022 (USD Million)
  • 4.3. Right ventricular assist device
    • 4.3.1. Right ventricular assist device market estimates and forecasts, 2012 - 2022 (USD Million)
  • 4.4. Bi-ventricular assist device
    • 4.4.1. Bi-ventricular assist device market estimates and forecasts, 2012 - 2022 (USD Million)

Chapter 5. Ventricular Assist device Regional Outlook

  • 5.1. Ventricular assist device market share, by region, 2014 & 2022
  • 5.2. North America
    • 5.2.1. North America ventricular assist device market estimates and forecasts, by product, 2012 - 2022
      • 5.2.1.1. U.S. ventricular assist device market estimates and forecasts, 2012 - 2022
      • 5.2.1.2. Canada ventricular assist device market estimates and forecasts, 2012 - 2022
  • 5.3. Europe
    • 5.3.1. Europe ventricular assist device market estimates and forecasts, by product, 2012 - 2022
      • 5.3.1.1. UK ventricular assist device market estimates and forecasts, 2012 - 2022
      • 5.3.1.2. Germany ventricular assist device market estimates and forecasts, 2012 - 2022
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific ventricular assist device market estimates and forecasts, by product, 2012 - 2022
      • 5.4.1.1. Japan ventricular assist device market estimates and forecasts, 2012 - 2022
      • 5.4.1.2. China ventricular assist device market estimates and forecasts, 2012 - 2022
      • 5.4.1.3. India ventricular assist device market estimates and forecasts, 2012 - 2022
  • 5.5. Latin America
    • 5.5.1. Latin America ventricular assist device market estimates and forecasts, by product, 2012 - 2022
      • 5.5.1.1. Brazil ventricular assist device market estimates and forecasts, 2012 - 2022
      • 5.5.1.2. Mexico ventricular assist device market estimates and forecasts, 2012 - 2022
  • 5.6. MEA
    • 5.6.1. MEA ventricular assist device market estimates and forecasts, by product, 2012 - 2022
      • 5.6.1.1. South Africa ventricular assist device market estimates and forecasts, 2012 - 2022

Chapter 6. Competitive Landscape

  • 6.1. Abiomed
    • 6.1.1. Company Overview
    • 6.1.2. Financial Performance
    • 6.1.3. Product Benchmarking
    • 6.1.4. Strategic Initiatives
  • 6.2. HeartWare International
    • 6.2.1. Company Overview
    • 6.2.2. Financial Performance
    • 6.2.3. Product Benchmarking
    • 6.2.4. Strategic Initiatives
  • 6.3. Thoratec
    • 6.3.1. Company Overview
    • 6.3.2. Financial Performance
    • 6.3.3. Product Benchmarking
    • 6.3.4. Strategic Initiatives
  • 6.4. Berlin Heart
    • 6.4.1. Company Overview
    • 6.4.2. Financial Performance
    • 6.4.3. Product Benchmarking
    • 6.4.4. Strategic Initiatives
  • 6.5. Cardiac Assist
    • 6.5.1. Company Overview
    • 6.5.2. Financial Performance
    • 6.5.3. Product Benchmarking
    • 6.5.4. Strategic Initiatives
  • 6.6. Jarvik Heart
    • 6.6.1. Company Overview
    • 6.6.2. Financial Performance
    • 6.6.3. Product Benchmarking
    • 6.6.4. Strategic Initiatives
  • 6.7. Reliantheart
    • 6.7.1. Company Overview
    • 6.7.2. Financial Performance
    • 6.7.3. Product Benchmarking
    • 6.7.4. Strategic Initiatives
  • 6.8. Sun Medical Technology Research
    • 6.8.1. Company Overview
    • 6.8.2. Financial Performance
    • 6.8.3. Product Benchmarking
    • 6.8.4. Strategic Initiatives

List of Tables

  • TABLE 1: Ventricular Assist Device Market - Industry Summary & Key Buying Criteria, 2012 - 2022
  • TABLE 2: Global ventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 3: Global ventricular assist Device market, by application, 2012 - 2022 (USD Million)
  • TABLE 5: Ventricular assist Device market, by region, 2012 - 2022 (USD Million)
  • TABLE 6: Ventricular assist Device market - Key market driver analysis
  • TABLE 7: Ventricular assist Device market - Key market restraint analysis
  • TABLE 8: Global cardiovascular diseases market, by disease type, 2012 - 2022 (USD Million)
  • TABLE 9: North America ventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 10: U.S. ventricular assist Device market, by product, 2012 - 2022 (USD Million
  • TABLE 11: Canada ventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 12: Europe ventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 13: UKventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 14: Germany ventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 15: Asia Pacific ventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 16: Japan ventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 17: China ventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 18: Latin America ventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 19: Brazil ventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 20: Mexico ventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 21: MEA ventricular assist Device market, by product, 2012 - 2022 (USD Million)
  • TABLE 22: South Africa ventricular assist Device market, by product, 2012 - 2022 (USD Million)

List of Figures

  • FIG. 1: Ventricular Assist Device market segmentation
  • FIG. 2: Global Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 3: Ventricular Assist Device market dynamics
  • FIG. 4: Global geriatric population, 2012 - 2022 (Million)
  • FIG. 5: Key Opportunities Prioritized- Product
  • FIG. 6: Ventricular Assist Device market - Porter's analysis
  • FIG. 7: Ventricular Assist Device market PESTEL analysis
  • FIG. 8: Company market share analysis, 2014
  • FIG. 9: Ventricular Assist Device revenue share by product, 2014 & 2022
  • FIG. 10: Left ventricular assist Device market, 2012 - 2022 (USD Million)
  • FIG. 11: Right ventricular assist Device market, 2012 - 2022 (USD Million)
  • FIG. 12: Bi-ventricular assist Device market, 2012 - 2022 (USD Million)
  • FIG. 13: Ventricular Assist Device market share, by region, 2014 & 2022
  • FIG. 14: North America Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 15: U.S. Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 16: Canada Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 17: Europe Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 18: UK Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 19: Germany Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 20: Asia Pacific Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 21: Japan Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 22: China Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 23: Latin America vascular market, 2012 - 2022 (USD Million)
  • FIG. 24: Brazil Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 25: Mexico Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 26: MEA Ventricular Assist Device market, 2012 - 2022 (USD Million)
  • FIG. 27: South Africa Ventricular Assist Device market, 2012 - 2022 (USD Million)
Back to Top